Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the HER2CLIMB Trial von Lin, Nancy U., Borges, Virginia, Anders, Carey, Murthy, Rashmi K., Paplomata, Elisavet, Hamilton, Erika, Hurvitz, Sara, Loi, Sherene, Okines, Alicia, Abramson, Vandana, Bedard, Philippe L., Oliveira, Mafalda, Mueller, Volkmar, Zelnak, Amelia, DiGiovanna, Michael P., Bachelot, Thomas, Chien, A. Jo, O'Regan, Ruth, Wardley, Andrew, Conlin, Alison, Cameron, David, Carey, Lisa, Curigliano, Giuseppe, Gelmon, Karen, Loibl, Sibylle, Mayor, JoAl, McGoldrick, Suzanne, An, Xuebei, Winer, Eric P.

Volltext

Fertility preservation before breast cancer treatment appears unlikely to affect disease‐free survival at a median follow‐up of 43 months after fertility‐preservation consultation... von Letourneau, Joseph M., Wald, Kaitlyn, Sinha, Nikita, Juarez‐Hernandez, Flor, Harris, Eve, Cedars, Marcelle I., McCulloch, Charles E., Dolezal, Milana, Chien, A. Jo, Rosen, Mitchell P.

Volltext

Random start ovarian stimulation for fertility preservation appears unlikely to delay initiation of neoadjuvant chemotherapy for breast cancer von Letourneau, Joseph M., Sinha, Nikita, Wald, Kaitlyn, Harris, Eve, Quinn, Molly, Imbar, Tal, Mok-Lin, Evelyn, Chien, A. Jo, Rosen, Mitchell

Volltext

The efficacy and safety of enzalutamide with trastuzumab in patients with HER2+ and androgen receptor-positive metastatic or locally advanced breast cancer von Wardley, Andrew, Cortes, Javier, Provencher, Louise, Miller, Kathy, Chien, A. Jo, Rugo, Hope S., Steinberg, Joyce, Sugg, Jennifer, Tudor, Iulia C., Huizing, Manon, Young, Robyn, Abramson, Vandana, Bose, Ron, Hart, Lowell, Chan, Stephen, Cameron, David, Wright, Gail S., Graas, Marie-Pascale, Neven, Patrick, Rocca, Andrea, Russo, Stefania, Krop, Ian E.

Volltext

Multidisciplinary Management of Cancer During Pregnancy von Silverstein, Jordyn, Post, Annalisa L., Chien, A. Jo, Olin, Rebecca, Tsai, Katy K., Ngo, Zoe, Van Loon, Katherine

Volltext

Concomitant tamoxifen or letrozole for optimal oocyte yield during fertility preservation for breast cancer: the TAmoxifen or Letrozole in Estrogen Sensitive tumors (TALES) randomi... von Letourneau, Joseph, Juarez-Hernandez, Flor, Wald, Kaitlyn, Ribeiro, Salustiano, Wang, Ange, McCulloch, Charles E., Mok-Lin, Evelyn, Dolezal, Milana, Chien, A. Jo, Cedars, Marcelle I., Rosen, Mitchell

Volltext

Acute ovarian failure underestimates age‐specific reproductive impairment for young women undergoing chemotherapy for cancer von Letourneau, Joseph M., Ebbel, Erin E., Katz, Patricia P., Oktay, Kutluk H., McCulloch, Charles E., Ai, Wei Z., Chien, A. Jo, Melisko, Michelle E., Cedars, Marcelle I., Rosen, Mitchell P.

Volltext

Final findings from the CONTROL trial: Strategies to reduce the incidence and severity of neratinib-associated diarrhea in patients with HER2-positive early-stage breast cancer von Chan, Arlene, Ruiz-Borrego, Manuel, Marx, Gavin, Chien, A. Jo, Rugo, Hope S., Brufsky, Adam, Thirlwell, Michael, Trudeau, Maureen, Bose, Ron, García-Sáenz, José A., Egle, Daniel, Pistilli, Barbara, Wassermann, Johanna, Cheong, Kerry A., Schnappauf, Benjamin, Semsek, Dieter, Singer, Christian F., Foruzan, Navid, DiPrimeo, Daniel, McCulloch, Leanne, Hurvitz, Sara A., Barcenas, Carlos H.

Volltext

Circulating tumor DNA and magnetic resonance imaging to predict neoadjuvant chemotherapy response and recurrence risk von Magbanua, Mark Jesus M., Li, Wen, Wolf, Denise M., Yau, Christina, Hirst, Gillian L., Swigart, Lamorna Brown, Newitt, David C., Gibbs, Jessica, Delson, Amy L., Kalashnikova, Ekaterina, Aleshin, Alexey, Zimmermann, Bernhard, Chien, A. Jo, Tripathy, Debu, Esserman, Laura, Hylton, Nola, van ‘t Veer, Laura

Volltext

Cellular Mechanisms of Resistance to Anthracyclines and Taxanes in Cancer: Intrinsic and Acquired von Chien, A. Jo, Moasser, Mark M

Volltext

A phase II study of lapatinib and bevacizumab as treatment for HER2-overexpressing metastatic breast cancer von Rugo, Hope S., Jo Chien, A., Franco, Sandra X., Stopeck, Alison T., Glencer, Alexa, Lahiri, Soumi, Arbushites, Michael C., Scott, Janet, Park, John W., Hudis, Clifford, Nulsen, Ben, Dickler, Maura N.

Volltext

The incidence of discordant clinical and genomic risk in patients with invasive lobular or ductal carcinoma of the breast: a National Cancer Database Study von Abel, Mary Kathryn, Shui, Amy M., Melisko, Michelle, Chien, A. Jo, Yoshida, Emi J., Lancaster, Elizabeth M., Van ‘T Veer, Laura, Esserman, Laura J., Mukhtar, Rita A.

Volltext

53 The development of a multi-institutional prospective registry for patients with metastatic invasive lobular carcinoma: identifying new markers of disease progression von Rothschild, Harriet T, Chien, A Jo, Jankowitz, Rachel C, Magbanua, Mark JM, Mouabbi, Jason A, Shatsky, Rebecca A, Levine, Julia, Mukhtar, Rita A

Volltext

Tamoxifen or aromatase inhibitors with ovarian function suppression in pre-menopausal stage I-III lobular breast cancer von Record, Helena, Clelland, Elle, Rothschild, Harriet T., Kaur, Mandeep, Chien, A. Jo, Melisko, Michelle, Rugo, Hope S., Mujir, Firdows, Huppert, Laura, Mukhtar, Rita A.

Volltext

Decreased enrollment in breast cancer trials by histologic subtype: does invasive lobular carcinoma resist RECIST? von Abel, Mary Kathryn, Melisko, Michelle E., Rugo, Hope S., Chien, A. Jo, Diaz, Italia, Levine, Julia K., Griffin, Ann, McGuire, Joseph, Esserman, Laura J., Borno, Hala T., Mukhtar, Rita A.

Volltext

Developing Safety Criteria for Introducing New Agents into Neoadjuvant Trials von DEMICHELE, Angela, BERRY, Donald A, BENZ, Chris, JO CHIEN, A, HALUSKA, Paul, LEYLAND-JONES, Brian, LIU, Minetta C, MUNSTER, Pamela, OLOPADE, Olufunmilayo, PARK, John W, PARKER, Barbara A, PUSZTAI, Lajos, ZUJEWSKI, Joanne, TRIPATHY, Debu, RUGO, Hope, YEE, Douglas, ESSERMAN, Laura, HUNSBERGER, Sally, RUBINSTEIN, Larry, TOMASZEWSKI, Joseph E, KELLOFF, Gary, BUXTON, Jane Perlmuttermeredith, LYANDRES, Julia, ALBAIN, Kathy S

Volltext

Mechanism of action biomarkers predicting response to AKT inhibition in the I-SPY 2 breast cancer trial von Wolf, Denise M., Yau, Christina, Wulfkuhle, Julia, Brown-Swigart, Lamorna, Gallagher, Rosa I., Jesus M. Magbanua, Mark, O’Grady, Nick, Hirst, Gillian, Asare, Smita, Tripathy, Debu, Berry, Don, Esserman, Laura, Chien, A. Jo, Petricoin, Emanuel F., van ‘t Veer, Laura

Volltext

53 The development of a multi-institutional prospective registry for patients with metastatic invasive lobular carcinoma: identifying new markers of disease progression – CORRIGEND... von Rothschild, Harriet T, Jo Chien, A, Jankowitz, Rachel C, Magbanua, Mark JM, Mouabbi, Jason A, Shatsky, Rebecca A, Levine, Julia, Mukhtar, Rita A

Volltext

The impact of an electronic health questionnaire on symptom management and behavior reporting for breast cancer survivors von Bock, Meredith, Moore, Dan, Hwang, Jimmy, Shumay, Dianne, Lawson, Laurell, Hamolsky, Deborah, Esserman, Laura, Rugo, Hope, Chien, A. Jo, Park, John, Munster, Pamela, Melisko, Michelle

Volltext

Emerging treatment options for the management of brain metastases in patients with HER2-positive metastatic breast cancer von Chien, A. Jo, Rugo, Hope S.

Volltext